HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Camptosar

HCID 60837
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
136572-09-3
Standard SMILES
CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC.Cl.O.O.O
InChIKey
KLEAIHJJLUAXIQ-JDRGBKBRSA-N
Molecular formula
C33H45ClN4O9
Average molar mass
677.2 g/mol
Monoisotopic mass
676.2875067

Overview

Irinotecan hydrochloride hydrate is a hydrate that is the trihydrate form of irinotecan hydrochloride. Onivyde is used in combination with fluorouracil and leucovorin, for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy. It is converted via hydrolysis of the carbamate linkage to its active metabolite, SN-38, which is ~1000 times more active. It has a role as an antineoplastic agent, a prodrug, an EC 5.99.1.2 (DNA topoisomerase) inhibitor and an apoptosis inducer. It contains an irinotecan hydrochloride (anhydrous).

Names & identifiers

Preferred name
Camptosar
IUPAC
[(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate;trihydrate;hydrochloride
English name
Irinotecan hydrochloride trihydrate
Molecular formula
C33H45ClN4O9
Molecular weight
677.18

Names & synonyms

CamptosarIrinotecan hydrochloride hydrateCHEBI:90881RefChem:148744(4S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinolin-9-yl (1,4'-bipiperidine)-1'-carboxylate monohydrochloride trihydrateIRINOTECAN HYDROCHLORIDE Trihydrate136572-09-3Irinotecan Hcl TrihydrateCPT-11 TrihydrateMFCD01765731Irinotecan (hydrochloride trihydrate)(+)-7-Ethyl-10-hydroxycamptothecine 10-(1,4'-bipiperidine)-1'-carboxylate, monohydrochloride, trihydrate
Show more names
Iriontecan HCLIrinotecan HCL 3H2OIrinotecan HydrochLIrinotecan TrihydrateCPT-11 HCl TrihydrateIrinotecan HydrochloridIRINOTECON HCL TRIHYDRATEVincristine-d 3 -1 sulfate
IRINOTECAN HYDROCHLORIDE [ORANGE BOOK](S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl [1,4'-bipiperidine]-1'-carboxylate hydrochloride trihydrate[(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate;trihydrate;hydrochlorideIrinotecan HCI TrihydrateUNII-042LAQ1IISCamptosar (TN)[1,4'-Bipiperidine]-1'-carboxylic acid (4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester monohydrochloride trihydrate; Irinotecan hydrochloride hydrate; Irinotecan hydrochloride trihydrateOnivyde (TN)

Properties

Computed structural properties

Topological polar surface area
116 Ų
Hydrogen bond donors
5
Hydrogen bond acceptors
11
Rotatable bonds
5
Heavy atoms
47
Formal charge
0
Complexity
1,200

Experimental & physicochemical properties

Human Drugs · 2 items

Breast Feeding; Lactation; Milk, Human; Antineoplastic Agents; Enzyme Inhibitors; Topoisomerase I Inhibitors

EMA approved medicines: Human medicine (Orphan designations)

Physicochemical properties

Melting point
250 · 250-256°C (dec.)
Boiling point
257 °C · 257°C(lit.)
storage temp.
2 · 2-8°C
solubility
Soluble in DMSO (up to 50 mg/ml), in Water (up to 4 mg/ml) or in Ethanol (up to 4 mg/ml).
form
White solid.
color
Yellow
Water Solubility
100 mg/ml · Soluble in DMSO at 100mg/ml. Soluble in water at 25mg/ml with warming
Merck
14 · 14,5091
Stability
1 year · Stable for 1 year from date of purchase as supplied. Solutions in DMSO, ethanol or distilled water may be stored at -20° for up to 3 months.
Major Application
pharmaceutical (small molecule)

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Toxicology

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

Safety data

wgk
WGK 3
rtecs
DW1060750
hs_code
29349990
Toxicity
dog,LD50,intravenous,40mg/kg (40mg/kg),Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 26, Pg. 953, 1995.
risk_code
22
Signal word
Danger
Symbol(GHS)
GHS07,GHS08
safety_code
20/21-22
Storage Class
11 - Combustible Solids
Hazard statements
H302-H372
Hazard Classifications
Acute Tox. 4 Oral
Precautionary statements
P260-P264b-P270-P301+P312-P314-P330-P403-P501c

Chemistry & industry

Pharmacology

MeSH Pharmacological ClassificationCompounds that inhibit the activity of DNA TOPOISOMERASE I.
Applications · 2 items

DescriptionIrinotecan (136572-09-3) is a semi-synthetic derivative of camptothecin (Cat.# 10-1041) that is an FDA approved anticancer drug. It is a prodrug that is converted by tissue esterases to 7-ethyl-10-hydroxycamptothecin (SN-38, Cat.# 10-2425), a potent inhibitor of DNA topoisomerase I.1,2 Although irinotecan is also a topoisomerase inhibitor, SN-38 is approximately 1000 times as potent in purified enzyme studies. In vitro cytotoxicity assays show much greater variability in potency between the two (2-2000 fold).3

UsesIrinotecan Hydrochloride Trihydrate is a DNA topoisomerase inhibitor.

Upstream & downstream products

Upstream raw materials

Irinotecan hydrochlorideHydrochloric acidEthanolWater
Additional notes · 1 item

DefinitionChEBI: A hydrate that is the trihydrate form of irinotecan hydrochloride. Onivyde is used in combination with fluorouracil and leucovorin, for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine based therapy. It is converted via hydrolysis of the carbamate linkage to its active metabolite, SN-38, which is ~1000 times more active.

Related reactions

6 records
New reaction record
HRID 631180 reaction equation
HRID 631180As product
HRID 1614850 reaction equation
HRID 1614850As reactant
HRID 2115182 reaction equation
HRID 2115182As product
HRID 2115183 reaction equation
HRID 2115183As product
HRID 2115184 reaction equation
HRID 2115184As product
HRID 2115185 reaction equation
HRID 2115185As product

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
136572-09-3
PubChem CID
60837
DTXSID
DTXSID60929485
ChEMBL
CHEMBL1200512
ChEBI
CHEBI:90881
UNII
042LAQ1IIS
InChIKey
KLEAIHJJLUAXIQ-VRWBIZLENA-N
SMILES
N1(C2CCN(C(OC3C=CC4C(C=3)=C(CC)C3CN5C(C=3N=4)=CC3[C@](CC)(O)C(=O)OCC=3C5=O)=O)CC2)CCCCC1.[H]Cl.[H]O[H].[H]O[H].[H]O[H] |&1:24,r|
CAS DataBase Reference
136572 · 136572-09-3(CAS DataBase Reference)
FDA UNII
42 LAQ1IIS · 042LAQ1IIS
UNSPSC Code
41116107 · 41116107
NACRES
24 · NA.24
Symbol(GHS)
7 · GHS07,GHS08
Signal word
Danger
Hazard statements
302 · H302-H372
Precautionary statements
260 · P260-P264b-P270-P301+P312-P314-P330-P403-P501c
Risk Statements
22 · 22
Safety Statements
20 · 20/21-22
WGK Germany
3 · WGK 3
RTECS
1060750 · DW1060750
HS Code
29349990 · 29349990
Storage Class
11 · 11 - Combustible Solids
Hazard Classifications
4 Oral · Acute Tox. 4 Oral
Toxicity
50 · dog,LD50,intravenous,40mg/kg (40mg/kg),Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 26, Pg. 953, 1995.